IndraLab

Statements

USP9X activates ciguatoxin CTX1B. 1 / 1

| 1

reach

"Pain alleviation was seen in 25% of patients treated with CTX and in 64% of those treated with FAM ' (P less than.01)."

3838343

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP9X activates ciguatoxin CTX1B. 1 / 1

INDRA sources:

Databases

Reading